Published in Neuro Oncol on September 01, 2012
Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist (2014) 0.98
Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro Oncol (2013) 0.94
Medical management of brain tumors and the sequelae of treatment. Neuro Oncol (2014) 0.94
Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years. Neuro Oncol (2013) 0.87
Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas. Neuro Oncol (2015) 0.87
Seizures and gliomas - towards a single therapeutic approach. Nat Rev Neurol (2016) 0.83
Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps. Eur Radiol (2015) 0.81
Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas. Cochrane Database Syst Rev (2015) 0.81
Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide. J Neurooncol (2015) 0.80
Pathological neural attractor dynamics in slowly growing gliomas supports an optimal time frame for white matter plasticity. PLoS One (2013) 0.80
Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro Oncol (2015) 0.79
Epilepsy associated tumors: Review article. World J Clin Cases (2014) 0.78
Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report. Neuro Oncol (2016) 0.78
Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: a gene expression imaging study. Epilepsy Res (2014) 0.78
Seizures in children with dysembryoplastic neuroepithelial tumors of the brain--A review of surgical outcomes across several studies. Childs Nerv Syst (2015) 0.78
Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro Oncol (2014) 0.78
The New Antiepileptic Drugs: Their Neuropharmacology and Clinical Indications. Neurol Med Chir (Tokyo) (2016) 0.77
Expression of RINT1 predicts seizure occurrence and outcomes in patients with low-grade gliomas. J Cancer Res Clin Oncol (2014) 0.76
Clinical Management of Seizures in Patients With Low-Grade Glioma. Semin Radiat Oncol (2015) 0.76
Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study. BMC Neurol (2014) 0.75
Long-range and short-range tumor-stroma networks synergistically contribute to tumor-associated epilepsy. Oncotarget (2016) 0.75
Epilepsy and brain tumors. Handb Clin Neurol (2016) 0.75
Prognostic relevance of epilepsy at presentation in lower-grade gliomas. Neuro Oncol (2016) 0.75
Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis. Br J Clin Pharmacol (2016) 0.75
Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study. J Neurol (2017) 0.75
Brain Tumor-Related Epilepsy: a Current Review of the Etiologic Basis and Diagnostic and Treatment Approaches. Curr Neurol Neurosci Rep (2017) 0.75
Activation of the mTOR signaling pathway in peritumoral tissues can cause glioma-associated seizures. Neurol Sci (2016) 0.75
Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Clin Transl Oncol (2017) 0.75
Incidental diffuse low-grade gliomas: from early detection to preventive neuro-oncological surgery. Neurosurg Rev (2015) 0.75
Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study. Oncol Lett (2017) 0.75
Epilepsy surgery for pediatric low-grade gliomas of the cerebral hemispheres: neurosurgical considerations and outcomes. Childs Nerv Syst (2016) 0.75
Glioneuronal tumors of cerebral hemisphere in children: correlation of surgical resection with seizure outcomes and tumor recurrences. Childs Nerv Syst (2016) 0.75
Controversies in management of low-grade gliomas in light of new data from clinical trials. Neuro Oncol (2017) 0.75
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med (2010) 8.28
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet (2005) 3.77
Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci U S A (2001) 3.14
Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol (2002) 2.98
TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain (2006) 2.80
Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol (1997) 2.71
Cognitive deficits in adult patients with brain tumours. Lancet Neurol (2004) 2.71
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology (2007) 2.52
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2000) 2.32
Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc (2004) 2.29
Retracted Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia (2003) 2.24
Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res (2007) 2.03
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol (2007) 2.02
Intractable epilepsy in paralimbic Word Health Organization Grade II gliomas: should the hippocampus be resected when not invaded by the tumor? J Neurosurg (2012) 2.01
Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol (2003) 2.00
An unexpected role for ion channels in brain tumor metastasis. Exp Biol Med (Maywood) (2008) 2.00
Glutamate release by primary brain tumors induces epileptic activity. Nat Med (2011) 2.00
Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol (2007) 1.97
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol (2004) 1.97
Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article. J Neurosurg (2011) 1.93
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol (2003) 1.92
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol (2010) 1.85
Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology (2008) 1.81
Small-world networks and epilepsy: graph theoretical analysis of intracerebrally recorded mesial temporal lobe seizures. Clin Neurophysiol (2007) 1.81
Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg (2008) 1.79
Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol (2003) 1.76
Medically intractable epilepsy from insular low-grade gliomas: improvement after an extended lesionectomy. Acta Neurochir (Wien) (2002) 1.67
Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol (2003) 1.64
Low-grade oligodendroglioma responds to chemotherapy. Neurology (1996) 1.56
Supratentorial low-grade gliomas in older patients. Neurology (2009) 1.55
A role for glutamate in growth and invasion of primary brain tumors. J Neurochem (2008) 1.48
How do brain tumors alter functional connectivity? A magnetoencephalography study. Ann Neurol (2006) 1.38
Preferential brain locations of low-grade gliomas. Cancer (2004) 1.32
Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol (2003) 1.31
Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther (2008) 1.26
The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia (2003) 1.26
Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol (2006) 1.26
Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer (2004) 1.23
Simple and complex dysembryoplastic neuroepithelial tumors (DNT) variants: clinical profile, MRI, and histopathology. Neuroradiology (2009) 1.22
The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien) (2000) 1.20
Malformations of cortical development and epilepsies: neuropathological findings with emphasis on focal cortical dysplasia. Epileptic Disord (2009) 1.20
Surgery of low-grade gliomas: towards a 'functional neurooncology'. Curr Opin Oncol (2009) 1.16
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J Neurooncol (2005) 1.15
Synchronized brain activity and neurocognitive function in patients with low-grade glioma: a magnetoencephalography study. Neuro Oncol (2008) 1.14
Prognostic factors and outcome after different types of resection for temporal lobe epilepsy. J Neurosurg (2002) 1.14
Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis. Expert Rev Anticancer Ther (2011) 1.13
Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. J Neurol Neurosurg Psychiatry (1994) 1.10
Temporal lobe tumoral epilepsy: characteristics and predictors of surgical outcome. Neurology (2003) 1.09
Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1. Leukemia (2004) 1.07
Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg (2011) 1.06
Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol (2009) 1.06
Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow-up of seizure outcome after surgery. Epilepsy Res (2001) 1.06
Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol (2001) 1.05
Brain tumors and epilepsy: pathophysiology of peritumoral changes. Neurosurg Rev (2009) 1.05
Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure (2003) 1.05
Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays. J Pharmacol Exp Ther (2006) 1.05
Epilepsy is related to theta band brain connectivity and network topology in brain tumor patients. BMC Neurosci (2010) 1.04
Epilepsy and brain tumors. Curr Opin Oncol (2010) 1.03
Morphological characteristics of brain tumors causing seizures. Arch Neurol (2010) 1.01
Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg (2007) 1.00
Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience (2003) 1.00
Seizures and the natural history of World Health Organization Grade II gliomas: a review. Neurosurgery (2011) 1.00
Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol (2006) 1.00
Tumor recurrence and malignant progression of gangliogliomas. Cancer (2008) 0.99
Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity. Ann Oncol (2001) 0.99
PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery (1998) 0.98
Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection. J Neurosurg (1993) 0.98
Electrocorticographic discharge patterns in glioneuronal tumors and focal cortical dysplasia. Epilepsia (2006) 0.96
Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. Eur J Neurol (2007) 0.96
Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. Neuro Oncol (2011) 0.95
Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia (2011) 0.95
Metabolic findings on 3T 1H-MR spectroscopy in peritumoral brain edema. AJNR Am J Neuroradiol (2007) 0.94
Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy. Neuropathol Appl Neurobiol (2005) 0.94
The application of stereotactic radiosurgery to disorders of the brain. Neurosurgery (2008) 0.94
Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neurooncol (2009) 0.94
Drug transporters in the epileptic brain. Epilepsia (2007) 0.93
Optimizing therapy of seizures in patients with brain tumors. Neurology (2006) 0.93
Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg (2011) 0.93
Efficacy of intraoperative electrocorticography for assessing seizure outcomes in intractable epilepsy patients with temporal-lobe-mass lesions. Seizure (2006) 0.92
Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study. Arch Neurol (2010) 0.92
Limbic and neocortical gliomas associated with intractable seizures: a distinct clinicopathological group. Neurosurgery (1994) 0.91
Seizure outcome of epilepsy surgery in focal epilepsies associated with temporomesial glioneuronal tumors: lesionectomy compared with tailored resection. J Neurosurg (2009) 0.90
Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors. J Neurooncol (2005) 0.90
Seizures in low- and high-grade gliomas: current management and future outlook. Expert Rev Anticancer Ther (2010) 0.90
Seizure prognosis of patients with low-grade tumors. Seizure (2012) 0.89
Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. Neuropathol Appl Neurobiol (2001) 0.88
Differential cellular gene expression in ganglioglioma. Epilepsia (2007) 0.88
Seizure disorders in patients with brain tumors. Eur Neurol (2001) 0.88
Clinical features and epileptogenesis of dysembryoplastic neuroepithelial tumor. Childs Nerv Syst (2006) 0.87
Gamma knife radiosurgery for refractory epilepsy caused by hypothalamic hamartomas. Stereotact Funct Neurosurg (2006) 0.87
Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy. Neurology (1993) 0.86
Primary and secondary mechanisms of epileptogenesis in the temporal lobe: there is a before and an after. Epilepsy Curr (2010) 0.86
Seizures in patients with low-grade gliomas--incidence, pathogenesis, surgical management, and pharmacotherapy. Adv Tech Stand Neurosurg (2010) 0.86
Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev (2008) 0.86
Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radiosurgery in low-grade gliomas. Acta Neurochir Suppl (1997) 0.86
Early surgical intervention in adult patients with ganglioglioma is associated with improved clinical seizure outcomes. J Clin Neurosci (2010) 0.85
Intraoperative electrocorticography during tumor resection: impact on seizure outcome in patients with gangliogliomas. J Neurosurg (1993) 0.85
Gene expression profile analysis of epilepsy-associated gangliogliomas. Neuroscience (2007) 0.84
Proton MRS of the peritumoral brain. J Neurol Sci (2004) 0.84
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol (2010) 6.15
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet (2009) 4.25
Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article. J Neurosurg (2013) 2.98
Intermittent general anesthesia with controlled ventilation for asleep-awake-asleep brain surgery: a prospective series of 140 gliomas in eloquent areas. Neurosurgery (2012) 2.74
Direct evidence for a parietal-frontal pathway subserving spatial awareness in humans. Science (2005) 2.68
Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol (2003) 2.43
Partial correlation for functional brain interactivity investigation in functional MRI. Neuroimage (2006) 2.26
Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol (2006) 2.20
Intractable epilepsy in paralimbic Word Health Organization Grade II gliomas: should the hippocampus be resected when not invaded by the tumor? J Neurosurg (2012) 2.01
Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Int J Cancer (2008) 1.93
Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article. J Neurosurg (2011) 1.93
Contrasting acute and slow-growing lesions: a new door to brain plasticity. Brain (2006) 1.74
Does the left inferior longitudinal fasciculus play a role in language? A brain stimulation study. Brain (2007) 1.66
Anatomic dissection of the inferior fronto-occipital fasciculus revisited in the lights of brain stimulation data. Cortex (2009) 1.59
Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer (2012) 1.56
Intraoperative subcortical electrical mapping of optic radiations in awake surgery for glioma involving visual pathways. J Neurosurg (2012) 1.55
Evidence for an occipito-temporal tract underlying visual recognition in picture naming. Clin Neurol Neurosurg (2009) 1.50
Ependymomas in adults. Curr Neurol Neurosci Rep (2010) 1.49
Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol (2007) 1.48
A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol (2012) 1.44
Simulation of anisotropic growth of low-grade gliomas using diffusion tensor imaging. Magn Reson Med (2005) 1.42
Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol (2012) 1.36
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol (2010) 1.25
Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J Biol Chem (2003) 1.23
What is the role of the uncinate fasciculus? Surgical removal and proper name retrieval. Brain (2010) 1.22
Awake mapping optimizes the extent of resection for low-grade gliomas in eloquent areas. Neurosurgery (2010) 1.20
Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery (2011) 1.20
Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates. Neurosurgery (2012) 1.19
Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Oncol (2008) 1.19
Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: towards a "minimal common brain". Neuroimage (2011) 1.18
Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model. J Neurooncol (2007) 1.15
Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Int J Cancer (2009) 1.12
Comparison of diffusion tensor imaging tractography of language tracts and intraoperative subcortical stimulations. J Neurosurg (2010) 1.12
Ependymomas of the adult: molecular biology and treatment. Curr Opin Neurol (2008) 1.10
Intraoperative electrical stimulation in awake craniotomy: methodological aspects of current practice. Neurosurg Focus (2010) 1.09
The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma. Br J Haematol (2008) 1.09
Frontal terminations for the inferior fronto-occipital fascicle: anatomical dissection, DTI study and functional considerations on a multi-component bundle. Brain Struct Funct (2011) 1.08
Regions, systems, and the brain: hierarchical measures of functional integration in fMRI. Med Image Anal (2008) 1.07
Long-term brain plasticity allowing a multistage surgical approach to World Health Organization Grade II gliomas in eloquent areas. J Neurosurg (2008) 1.07
Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol (2008) 1.07
Analysis of the subcomponents and cortical terminations of the perisylvian superior longitudinal fasciculus: a fiber dissection and DTI tractography study. Brain Struct Funct (2012) 1.06
Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model. Clin Cancer Res (2004) 1.06
Somatotopy of the supplementary motor area: evidence from correlation of the extent of surgical resection with the clinical patterns of deficit. Neurosurgery (2002) 1.05
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol (2013) 1.03
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol (2013) 1.03
Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas. Neuro Oncol (2013) 1.03
Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm. Neurosurg Rev (2008) 1.03
Epilepsy and brain tumors. Curr Opin Oncol (2010) 1.03
The functional architecture of the left posterior and lateral prefrontal cortex in humans. Cereb Cortex (2008) 1.02
Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect (2012) 1.02
Role of diffusion tensor magnetic resonance tractography in predicting the extent of resection in glioma surgery. Neuro Oncol (2011) 1.02
Seizures and the natural history of World Health Organization Grade II gliomas: a review. Neurosurgery (2011) 1.00
Natural history of incidental World Health Organization grade II gliomas. Ann Neurol (2010) 0.99
Direct electrical stimulation as an input gate into brain functional networks: principles, advantages and limitations. Acta Neurochir (Wien) (2009) 0.99
1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth. J Neurooncol (2012) 0.99
Unruptured intracranial aneurysms treated by three-dimensional coil embolization: evaluation of the postoperative aneurysm occlusion volume. Neuroradiology (2005) 0.99
Resection of World Health Organization Grade II gliomas involving Broca's area: methodological and functional considerations. Neurosurgery (2007) 0.99
Pregnancy increases the growth rates of World Health Organization grade II gliomas. Ann Neurol (2010) 0.99
French brain tumor database: 5-year histological results on 25 756 cases. Brain Pathol (2011) 0.98
Extension of paralimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns. J Neurooncol (2006) 0.98
Is the human left middle longitudinal fascicle essential for language? A brain electrostimulation study. Hum Brain Mapp (2010) 0.98
Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol (2005) 0.97
New insights into the anatomic dissection of the temporal stem with special emphasis on the inferior fronto-occipital fasciculus: implications in surgical approach to left mesiotemporal and temporoinsular structures. Neurosurgery (2010) 0.96
Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection. Neurosurg Rev (2009) 0.96
Preoperative estimation of residual volume for WHO grade II glioma resected with intraoperative functional mapping. Neuro Oncol (2006) 0.96
Cortex-sparing fiber dissection: an improved method for the study of white matter anatomy in the human brain. J Anat (2011) 0.96
Epileptic seizures in diffuse low-grade gliomas in adults. Brain (2013) 0.94
Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group. J Neurol (2009) 0.94
Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro Oncol (2013) 0.94
Cognition and resective surgery for diffuse infiltrative glioma: an overview. J Neurooncol (2012) 0.94
Brain lymphoma: usefulness of the magnetic resonance spectroscopy. J Neurooncol (2007) 0.94
Assessment of verbal working memory before and after surgery for low-grade glioma. J Neurooncol (2006) 0.93
Does the left superior longitudinal fascicle subserve language semantics? A brain electrostimulation study. Brain Struct Funct (2011) 0.93
Middle longitudinal fasciculus delineation within language pathways: a diffusion tensor imaging study in human. Eur J Radiol (2012) 0.92
The left inferior fronto-occipital fasciculus subserves language semantics: a multilevel lesion study. Brain Struct Funct (2014) 0.92
The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas. J Neuroimmunol (2013) 0.92
Re-operation is a safe and effective therapeutic strategy in recurrent WHO grade II gliomas within eloquent areas. Acta Neurochir (Wien) (2009) 0.92
Subcortical electrostimulation to identify network subserving motor control. Hum Brain Mapp (2012) 0.92
Brain hodotopy: from esoteric concept to practical surgical applications. Neurosurgery (2011) 0.92
Visualization of disconnection syndromes in humans. Cortex (2008) 0.91
A novel approach to clinical-radiological correlations: Anatomo-Clinical Overlapping Maps (AnaCOM): method and validation. Neuroimage (2007) 0.91
Mapping the connectivity underlying multimodal (verbal and non-verbal) semantic processing: a brain electrostimulation study. Neuropsychologia (2013) 0.90
Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo. Cancer Res (2003) 0.90
The anatomo-functional connectivity of word repetition: insights provided by awake brain tumor surgery. Front Hum Neurosci (2013) 0.90
Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models. Cancer Res (2007) 0.90
Surgical management of World Health Organization Grade II gliomas in eloquent areas: the necessity of preserving a margin around functional structures. Neurosurg Focus (2010) 0.89
Surgery for gliomas involving the left inferior parietal lobule: new insights into the functional anatomy provided by stimulation mapping in awake patients. J Neurosurg (2011) 0.88
Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012. Eur J Cancer (2012) 0.88
Inferring a dual-stream model of mentalizing from associative white matter fibres disconnection. Brain (2014) 0.87
Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells. Stem Cells (2015) 0.87
Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors. Cancer Res (2002) 0.87
The GluR2 subunit inhibits proliferation by inactivating Src-MAPK signalling and induces apoptosis by means of caspase 3/6-dependent activation in glioma cells. Eur J Neurosci (2009) 0.86
Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas. J Neurooncol (2007) 0.86
Processing of syntactically complex sentences relies on verbal short-term memory: evidence from a short-term memory patient. Cogn Neuropsychol (2007) 0.86
Cerebral correlates of visuospatial neglect: a direct cerebral stimulation study. Hum Brain Mapp (2013) 0.86
Skin metastases of glioblastoma in the absence of intracranial progression are associated with a shift towards a mesenchymal immunophenotype: report of two cases. Acta Neuropathol (2009) 0.85
Tolerance of awake surgery for glioma: a prospective European Low Grade Glioma Network multicenter study. Acta Neurochir (Wien) (2013) 0.85
Delayed leptomeningeal and subependymal seeding after multiple surgeries for supratentorial diffuse low-grade gliomas in adults. J Neurosurg (2013) 0.85